Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cells for steroid-refractory or steroid-dependent graft versus host disease
2013-003626-88Phase 2Completed
- Sponsor
- Fakultní nemocnice Plzeň
- Start
- Jan 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mesenchymal stem cells in graft-versus-host disease (GVHD), sponsored by Fakultní nemocnice Plzeň. Primary endpoint: Clinical response of GVHD. Started Jan 2014; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on 2013-003626-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003626-88.